Diabetes Mellitus Type 2 Clinical Trial
Official title:
Evaluation of Pressure Distribution of Kyboot Shoes in Comparison to Other Foot Wear in Diabetic Patients and in Healthy Subjects
Comparison and evaluation of pressure distribution, gait pattern, changes in the movement of the center of pressure, shock absorbing capabilities and comfort of wear using KyBoot shoes versus normal foot wear in diabetic and healthy subjects.
Every 30 seconds a limb is lost somewhere in the world as a consequence of diabetes. These
amputations are preceded by a foot ulcer in 84% of cases. Therefore, prevention of
ulceration is of utmost importance.
Approximately one-half of all diabetic foot ulcers occur on the plantar foot surface and are
mainly caused by elevated levels of mechanical pressure acting on the foot during ambulation
in the presence of lost protective foot sensation from peripheral neuropathy.
Therefore, to reduce risk of ulceration, relief of mechanical pressure (also called
offloading) is indicated.
Currently therapeutic footwear is provided by the Health maintenance organizations (HMO's)
to diabetic patients that are at risk of developing foot ulcers.
Ideal footwear for a diabetic patient decreases weight-bearing pressure and shear forces
applied to the skin of the foot by distributing the acting forces more evenly.
With the growth in the health and fitness industry, sports footwear has shown technological
advances and diversification.
The introduction of the KyBoot shoe is an example of this diversification. The Kybun company
based their shoe on the experience of walking on soft, muddy rice fields in Korea.
The Kyboot construction is based on a soft, supple air cushioned sole. The honeycomb air
structure of the kyBoot sole creates an air cushion between your foot and the ground, with
one fifth of the volume of air being pumped into the foot area at every step. This design
could offer a better distribution of pressure.
Therefore, in this study we would like to compare the pressure distribution, changes in the
movement of the center of pressure and shock absorbing capabilities of the KyBoot in
comparison with normal shoes.
Study goals:
Comparison and evaluation of pressure distribution, gait pattern, changes in the movement of
the center of pressure, shock absorbing capabilities and comfort of wear using KyBoot shoes
versus normal foot wear in diabetic and healthy subjects.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01267448 -
Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia
|
Phase 4 | |
Active, not recruiting |
NCT05330247 -
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
|
N/A | |
Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 | |
Terminated |
NCT02373865 -
Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT01741181 -
Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2
|
Phase 4 | |
Completed |
NCT01305434 -
Mulberry Leaf Extract and Blood Glucose Control in Diabetics
|
Phase 1/Phase 2 | |
Completed |
NCT01330121 -
Bridging the Gap by Transitional Care
|
N/A | |
Recruiting |
NCT00992797 -
Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity
|
Phase 2 | |
Completed |
NCT01580904 -
Impact of Pharmaceutical Care in Diabetics Patients
|
N/A | |
Active, not recruiting |
NCT00728403 -
Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes
|
Phase 2 | |
Completed |
NCT00763815 -
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
|
Phase 3 | |
Active, not recruiting |
NCT00529815 -
Continuous Glucose Monitoring in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT00517465 -
A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
|
Phase 1 | |
Withdrawn |
NCT00417716 -
Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema
|
Phase 3 | |
Completed |
NCT00119041 -
Diabetes Telemedicine Consultation: A Systems Improvement Intervention
|
N/A | |
Withdrawn |
NCT00600236 -
HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population
|
Phase 3 | |
Active, not recruiting |
NCT05887635 -
Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus
|
N/A | |
Completed |
NCT03903965 -
Comparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.
|
||
Completed |
NCT02666924 -
Cooking Classes for Chinese Canadian Patients Living With Diabetes
|
N/A | |
Recruiting |
NCT02501850 -
The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
|
Phase 4 |